A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Frank Detmers
Advertisement
Frank Detmers is Director of Ligand Applications, Bioproduction at Thermo Fisher Scientific (Leiden, The Netherlands)
Articles by Frank Detmers
Advertisement
Latest Updated Articles
Affinity Chromatography Accelerates Viral Vector Purification for Gene TherapiesPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
